TiumBio
A drug developer working on treatments for cancer based in South Korean. Learn more
Launch date
Employees
Market cap
AUD208m
Enterprise valuation
AUD215m (Public information from Sep 2024)
Share price
KRW6180 321550.KQ
Seongnam-si Gyeonggi-do (HQ)
Authorizing premium user...